Management of patients with ovarian cancer in the COVID‐19 era

At the beginning of 2020, coronavirus disease 2019 (COVID‐19) spreads worldwide. Patients with ovarian cancer should be considered at high‐risk of developing severe morbidity related to COVID‐19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the m...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Surg Oncol
Hlavní autoři: Bogani, Giorgio, Casarin, Jvan, Pinelli, Ciro, Di Donato, Violante, Bosio, Sara, Ruisi, Simona, Brusadelli, Claudia, Guerrisi, Rocco, Sarpietro, Giuseppe, Ditto, Antonino, Ghezzi, Fabio, Raspagliesi, Francesco
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300981/
https://ncbi.nlm.nih.gov/pubmed/32476155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.26057
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky